Was the 25 or 100 mg tablet really an accident, or is that a sales story?
The ping Sandwich logged before anyone named a diamond
Start at the lab book, not the blue tablet. The signal that matters is a 1986 project team at Pfizer's Sandwich site on the Kent coast, hunting a selective PDE5 blocker for chest pain.
Five phosphodiesterase families were on the map by the mid-1980s. PDE5 was the one that chewed cyclic GMP and left it. Nitric oxide raises that messenger; the messenger relaxes smooth muscle; PDE5 clears the messenger. Stop the clearance and a vessel stays open longer. Sandwich wanted that stay-open in coronary arteries. The chemistry that landed was a pyrazolopyrimidine. In 1989 the lead, UK-92,480, was selected for development. Against PDE5 from human platelets its IC50 sat at 3.5 nM, with a clean gap over PDE1 through PDE4. That is a designed molecule, not a lucky powder.
Preclinical work showed vasodilation, less platelet clumping, and less thrombus re-forming in a damaged carotid. Clinical entry followed in 1991. None of that was aimed at an erection. The enzyme they had chosen just happens to sit far denser in penile vessels than in the coronary bed they were watching. Geography wrote the later story. The current label for the tablet that came out of this file is in the sildenafil signal note.
Does a cheap 25 or 100 mg generic still carry that Kent file?
A price tag is not a new origin. The citrate is the citrate. What changed after the patents lapsed is who prints the blister, not what Sandwich synthesised.
US exclusivity on the brand ran out around 2012-2013. After that, a man could order a 25 or 100 mg tablet without paying for the diamond stamp. The file underneath did not move. Same PDE5 block. Same nitrate hold. Same food delay. A cheap generic is a manufacturing and price event. It is not a second discovery. Anyone selling a 'new formula' 25 mg on that story is selling noise.
What a buyer should still ping is the pharmacy, not the folklore. A licensed US counter fills a scored tablet that matches the labelled citrate. A loose blister with no lot and a cousin's review is not the Sandwich file wearing a discount. Reviews that skip the angina origin also skip why the hold exists. The molecule was built to drop vascular tone. That is why it works in erectile tissue and why it is lethal next to a nitrate, brand or generic, 25 or 100 mg.
UK-92,480 was a coronary bet, not a bedroom brief
Simon Campbell's chemistry group at Sandwich built the series. The brief on the wall was hypertension and angina, not a private complaint men would not name in 1989. Ian Osterloh later ran the early human work. First dosing sat at Morriston Hospital in Swansea. Volunteers took repeated doses. The heart numbers were polite and useless. Coronary flow nudged. Duration was short. As an anti-anginal, the compound was heading for the discard pile where most phase I files go.
Then the other line on the chart would not sit still. Men on multi-day dosing reported penile erections, sometimes after the tablet was supposed to be 'working' on the chest. Some were slow to say it. A few colourful retellings have them asking to keep leftover tablets. Treat those stories as colour, not as the mechanism. The usable signal was consistency: the side effect repeated across volunteers, and it mapped onto PDE5 density in erectile tissue. Pfizer had to decide whether to bury an inconvenient line or to reopen the file under a new heading.
Swansea did not rescue the chest; it redirected the file
The pivot was a judgement, not a press release. Plenty of drugs throw odd side effects that lead nowhere. This one led somewhere because the vascular biology was already on the page.
Blood has to stay in the penis for an erection to hold, and nitric oxide is the chemical that starts that stay. Arousal releases it in the corpus cavernosum. Cyclic GMP climbs. Smooth muscle lets go. Inflow fills the tissue and the outflow clamps. In erectile dysfunction that cascade is too weak to hold. Block PDE5 and the messenger hangs around, so an ordinary arousal signal yields a firmer, longer response. No arousal, no messenger, no event. That is why a 25 or 100 mg tablet does nothing as a light switch, and why the Sandwich team could read the side effect as pharmacology rather than as gossip.
By the mid-1990s the programme had left angina. The alternatives then were intracavernosal injections, vacuum devices, and implants. A swallowable tablet was a new kind of offer. By 1997 more than 4,500 people had taken the compound across 21 trials. Headache, flushing, dyspepsia, and a transient colour-vision shift were the dose-related flags. Nitrates were already a hard stop. That package, not a leftover-pill anecdote, is what went to the regulators. How those trials were scored sits in the IIEF trial note.
What 27 March 1998 actually licensed
1986
Sandwich project team forms to build a selective PDE5 inhibitor for angina and hypertension.
1989
UK-92,480 selected; IC50 3.5 nM on platelet PDE5. Clinical path opens.
1991
First human dosing. Angina signal stays weak. Erection reports repeat.
Mid-1990s
Programme redirects to erectile dysfunction. 21 trials, more than 4,500 exposed by 1997.
27 Mar 1998
FDA approves Viagra. Labelled ED tablets: 25, 50, 100 mg.
Sep 1998
European approval follows.
2005
Same citrate approved as Revatio for PAH at 20 mg three times daily.
2012-2013
US patents lapse. Cheap generic 25 or 100 mg arrives. The file does not.
The FDA signed Viagra, sildenafil citrate, on 27 March 1998. NDA 020895. First oral drug licensed in the United States for erectile dysfunction. Europe followed in September 1998. The labelled ED strengths were 25, 50, and 100 mg. This desk locks the SERP edges at 25 or 100 mg because those are the step-down and the ceiling a man actually argues about; 50 mg is the usual start, not a third origin story. The tablet was a blue diamond. The cultural noise was immediate. The clinical fact underneath was quieter: a condition men had hidden became a sentence they could say in a clinic.
That licence also dragged a vascular warning into daylight. Small penile arteries often fail before larger coronary ones announce themselves. New erectile failure, especially in a younger or middle-aged man, can be the first public ping of the same arterial disease that later hits the heart. A pill born as a failed heart drug sent some men to a cardiologist. That is not branding. That is the same endothelium. Cousins arrived later - tadalafil in 2003 with a long clock, vardenafil the same year with a tighter milligram ladder. They inherited the enzyme and the nitrate hold. They did not inherit the Sandwich file.
Revatio is a second file, not a sequel joke
The molecule looped back toward vessels, just not the ones Sandwich first named. Pulmonary arterial hypertension is a rare, ugly disease. Small lung arteries stiffen. The right heart pumps against a rising wall.
| Stamp | Viagra file | Revatio file |
|---|---|---|
| Job | Erectile dysfunction | Pulmonary arterial hypertension |
| Year | 1998 | 2005 |
| Usual tablet | 25 or 100 mg as needed (50 mg common start) | 20 mg three times daily |
| Shape people remember | Blue diamond | White round |
| Citrate | Sildenafil | Sildenafil |
| Nitrate hold | Absolute | Absolute |
Those lung vessels are packed with PDE5. Relax them and the right ventricle gets a cheaper job. In 2005 the FDA approved sildenafil for PAH as Revatio, 20 mg three times a day on a fixed clock. That schedule is not an ED trick. It is a different indication, a different brand, a different specialist. You do not improvise it from a leftover 100 mg diamond, and you do not treat a 20 mg three-times-daily bottle as a cheap way to stock 25 or 100 mg for the evening.
Same citrate. Two jobs. One hold that never splits. Nitrates - nitroglycerin, isosorbide, recreational nitrites sold as poppers - stay banned on both labels. Riociguat, a guanylate-cyclase stimulator, is banned with it too. The practical swallow for the ED tablet, including the empty-plate clock, is in the clock-and-plate guide.
Flag the leftover-tablet lore; keep the enzyme
The cartoon version says volunteers refused to hand the pills back and a marketer invented a lifestyle drug. The file says the chemistry was intentional, the application was the surprise, and the team had to be willing to kill its original endpoint. Most 'accidental' drugs are just unread side-effect columns. This one was read. That is the skill, not the luck.
Forum lore still sells the accident harder than the enzyme. Ignore the sales pitch that a 25 or 100 mg tablet 'creates' desire. It amplifies a nitric-oxide ping that arousal already sent. Ignore the pitch that generic 25 mg is a weaker story than brand 100 mg. Strength is a labelled milligram, not a myth. The hold, the food delay, and the need for stimulation travelled with the citrate from Sandwich to every pharmacy that later printed a cheap blister.
Post: the file taught a clinic to listen
Post the takeaway in one line. Sandwich built a PDE5 blocker for angina. The chest endpoint missed. The erection ping was real, repeatable, and mechanistically honest. 27 March 1998 put 25 or 100 mg on a US label. 2005 reused the citrate for lung pressure. Cheap generics changed the receipt, not the file.
If erections have been failing, the useful next ping is not a cart. It is a blood-pressure, sugar, and cholesterol check, plus a straight talk about nitrates before anyone names a strength. The molecule began as a heart drug that failed. It still points at vessels. Discuss a change in dose or drug with a clinician who has your list, then read the desk disclaimer before you treat a journal note as a plan.
Reader mail
Reader questions on this article
Answered by Dr. Elena Vasquez, MD · Urology & men's health
Readers pinged the Sandwich file after this note. These nine names asked the questions worth tracing in full.
The chemistry was no accident. Sandwich set out to build a PDE5 inhibitor for angina, coded it UK-92,480, and selected it in 1989 with a 3.5 nM IC50. What nobody ordered was the tissue where that block would shout. Early angina work was weak on the chest and loud on erections. The accident is the indication, not the molecule. Credit the team that killed its first endpoint and followed a consistent side-effect line. A cheap generic 25 or 100 mg tablet still carries that designed citrate. It does not carry a new origin.
Why did the angina file flop if the same enzyme later sold so hard?
PDE5 is not evenly spread. Penile vessels carry it densely. Coronary arteries, the target Sandwich named, do not give the same return. UK-92,480 nudged coronary flow and then faded too fast to be a useful anti-anginal. The identical block - preserve cyclic GMP, keep smooth muscle relaxed - found its strongest geography in erectile tissue. Same ping, different bed. That is why a failed heart endpoint and a usable erection signal can live in one molecule without a contradiction.
If I buy cheap generic 25 mg, am I buying a different story than brand 100 mg?
You are buying a different milligram and a different receipt, not a different file. After the US patents lapsed around 2012-2013, other manufacturers could print the citrate. A licensed 25 mg generic has to deliver the same active drug. Brand 100 mg is the ceiling on the ED ladder, not a holier molecule. What does not cheapen is the nitrate hold, the food delay, or the need for arousal. If the blister has no lot and the seller has no pharmacy name, that is not generic. That is a different, worse file.
Did men in Swansea really refuse to return leftover tablets?
People who were in the early rooms have said volunteers noticed the erectile effect and were reluctant to hand unused tablets back. Some were slow to mention it at all, which fits the era. I treat that as colour. The line that moved the company was not a single colourful refusal. It was a repeated, mechanistically plausible side effect during multi-day dosing, logged while the angina numbers stayed dull. Anecdotes travel. Consistency is what reopened the file.
Is Revatio just Viagra with a quieter name?
Same citrate, different file. Viagra is the 1998 ED brand, taken as needed, labelled 25, 50, and 100 mg. Revatio is the 2005 PAH brand, 20 mg three times a day on a fixed clock, written by a lung or heart specialist. You do not stock an evening 100 mg from a Revatio bottle, and you do not treat a cheap 25 mg diamond as lung therapy. The hold is shared: no nitrates, no riociguat. Everything else - schedule, strength, who signs - splits.
New erections failing - is that part of this history or a separate scare?
It is part of the same vessel story. The drug works because an erection is arterial. The processes that scar larger arteries - pressure, sugar, smoke, cholesterol - often show first in the narrower penile bed. So a new failure, especially before old age, can be an early ping, not a lifestyle punchline. Sandwich did not set out to invent a cardiology screening tool. The mechanism did that. Get the vascular check. Then talk about a 25 or 100 mg tablet. Do not reverse the order.
Why do people still talk about 1998 if injections already existed?
Because the older options asked a man to inject the penis, pump a cylinder, or accept an implant. Those can work. Most men would rather not start there. A swallowable 25 or 100 mg tablet, taken privately, changed who would walk into a clinic at all. That is as large as the pharmacology. Tadalafil and vardenafil exist because this file proved both the enzyme and the conversation. 1998 is a licence date and a social date. The cartoon only remembers the second.
Given it opens vessels, when is a 25 or 100 mg tablet actually dangerous?
The line that never moves is nitrates. Nitroglycerin, isosorbide, poppers. Both sides drop vascular tone. Together the drop can be sudden and fatal. That hold is absolute on 25 mg and on 100 mg, on brand and on cheap generic, on Viagra and on Revatio. Riociguat is the other hard no. Alpha-blockers need a stable background and a 25 mg start. Recent unstable heart disease, stroke, or a heart attack belongs in the room before anyone names a strength. Inside those fences the safety record is long. Across them it is not a bargain.
Where do I read the official file, not a forum recap?
Start with the labelled tablet, not a comment thread. The US prescribing information for Viagra is the stamp this desk traces - strengths, food delay, CYP3A4, nitrate hold. A readable walk through the current numbers is in the sildenafil signal note. For the regulator's own pages, use FDA and the DailyMed label set. If you want the trial scores rather than the origin, open the IIEF trial note. Bring your nitrate list to a clinician before you treat any of those pages as a personal plan.
General education from a clinician, not personal medical advice. Bring your own history to your own prescriber.
Last Updated